Significant progress in the battle against pancreatic cancer is emerging, thanks to a new medical breakthrough. An experimental drug, administered once daily, is showing potential in extending the lives of patients by slowing the advance of this highly lethal disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, discusses the promising outcomes with Stephanie Sy. The research indicates that this innovative treatment could represent a major step forward after years of dedicated study.
About Stephanie Sy
Stephanie Sy is currently a correspondent for PBS News Hour. She has extensive experience in journalism, having held positions as an anchor and correspondent for major networks including ABC News, Al Jazeera America, CBSN, CNN International, and PBS News Hour Weekend. Before her current role, she worked with Yahoo News where she covered the 2018 Midterm Elections and reported live from Donald Trump’s victory party on Election Day 2016.
Cancer Death Rates Decline in the U.S., But Disparities Remain 
COVID-19 Vaccine Study Highlights Effectiveness Amid Controversy 
Life Inside Biocontainment and Updates on Covid-19 Vaccine Policies 
Extreme Heat Risk Spreads Across the U.S. 
Efforts to Address Hospice Fraud and Strengthen Program Integrity 
CDC-Collected COVID-19 Vaccine Study Published Amid Methodological Debate